Boston Scientific Inc. (BSX): Today's Featured Health Services Winner
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
.
(
) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.5%. By the end of trading, Boston Scientific rose 27 cents (5.2%) to $5.50 on heavy volume. Throughout the day, 52.5 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 11.4 million shares. The stock ranged in a price between $5.18-$5.53 after having opened the day at $5.22 as compared to the previous trading day's close of $5.23. Other companies within the Health Services industry that increased today were:
(
), up 22%,
(
), up 11.5%,
NeuroMetrix
(
NUROD
), up 9.3%, and
(
), up 7.9%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $7.15 billion and is part of the health care sector. The company has a P/E ratio of -1.8, below the S&P 500 P/E ratio of 17.7. Shares are down 2.4% year to date as of the close of trading on Tuesday. Currently there are five analysts that rate Boston Scientific a buy, one analyst rates it a sell, and 15 rate it a hold.
TheStreet Ratings rates Boston Scientific as a
. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself.
- You can view the full Boston Scientific Ratings Report.
On the negative front,
(
), down 12.2%,
(
), down 11.1%,
Arrhythmia Research Technology
(
), down 9.1%, and
(
), down 8.8%, were all laggards within the health services industry with
(
) being today's health services industry laggard.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider
Health Care Select Sector SPDR
(
) while those bearish on the health services industry could consider
ProShares Ultra Short Health Care
(
).
- Find other investment ideas from our top rated ETFs lists.
FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!
.
null